Research Suggests We’re Passing “Peak Obesity”; Weight-Loss Drugs Are Likely Reason By Thierry Malleret, economist GLP-1 weight-loss drugs are a remarkable example of health and tech innovation that seems to be leading to a stunning reversal in obesity rates. New data shows an unprecedented decline in obesity levels, which fell about 2 percentage points between 2020 and 2023. The new study used weight and height…
